Lockbaum P - Search Results

1

Randomized, dose-escalation study of SD/01 compared with daily filgrastim in patients receiving chemotherapy.

Johnston E, Crawford J, Blackwell S, Bjurstrom T, Lockbaum P, Roskos L, Yang BB, Gardner S, Miller-Messana MA, Shoemaker D, Garst J, Schwab G. Johnston E, et al. Among authors: lockbaum p. J Clin Oncol. 2000 Jul;18(13):2522-8. doi: 10.1200/JCO.2000.18.13.2522. J Clin Oncol. 2000. PMID: 10893282 Clinical Trial.

2

Pharmacokinetic/pharmacodynamic modeling of pegfilgrastim in healthy subjects.

Roskos LK, Lum P, Lockbaum P, Schwab G, Yang BB. Roskos LK, et al. Among authors: lockbaum p. J Clin Pharmacol. 2006 Jul;46(7):747-57. doi: 10.1177/0091270006288731. J Clin Pharmacol. 2006. PMID: 16809800 Clinical Trial.

3

Dose escalation study of carboplatin and cyclophosphamide with filgrastim support: a phase I study.

Toner GC, Green M, Bishop JF, McKendrick J, Cebon J, Sheridan WP, Lockbaum P, O'Byrne J, Fox RM. Toner GC, et al. Among authors: lockbaum p. Am J Clin Oncol. 1998 Jun;21(3):263-9. doi: 10.1097/00000421-199806000-00012. Am J Clin Oncol. 1998. PMID: 9626795 Clinical Trial.

4

A new form of Filgrastim with sustained duration in vivo and enhanced ability to mobilize PBPC in both mice and humans.

Molineux G, Kinstler O, Briddell B, Hartley C, McElroy P, Kerzic P, Sutherland W, Stoney G, Kern B, Fletcher FA, Cohen A, Korach E, Ulich T, McNiece I, Lockbaum P, Miller-Messana MA, Gardner S, Hunt T, Schwab G. Molineux G, et al. Among authors: lockbaum p. Exp Hematol. 1999 Dec;27(12):1724-34. doi: 10.1016/s0301-472x(99)00112-5. Exp Hematol. 1999. PMID: 10641590 Free article.

5

Dose and schedule study of panitumumab monotherapy in patients with advanced solid malignancies.

Weiner LM, Belldegrun AS, Crawford J, Tolcher AW, Lockbaum P, Arends RH, Navale L, Amado RG, Schwab G, Figlin RA. Weiner LM, et al. Among authors: lockbaum p. Clin Cancer Res. 2008 Jan 15;14(2):502-8. doi: 10.1158/1078-0432.CCR-07-1509. Clin Cancer Res. 2008. PMID: 18223225 Clinical Trial.

6

Safety, pharmacokinetics, and activity of ABX-EGF, a fully human anti-epidermal growth factor receptor monoclonal antibody in patients with metastatic renal cell cancer.

Rowinsky EK, Schwartz GH, Gollob JA, Thompson JA, Vogelzang NJ, Figlin R, Bukowski R, Haas N, Lockbaum P, Li YP, Arends R, Foon KA, Schwab G, Dutcher J. Rowinsky EK, et al. Among authors: lockbaum p. J Clin Oncol. 2004 Aug 1;22(15):3003-15. doi: 10.1200/JCO.2004.11.061. Epub 2004 Jun 21. J Clin Oncol. 2004. PMID: 15210739

7

Chemotherapy of small-cell carcinoma of lung: a randomized comparison of alternating and sequential combination chemotherapy programs.

Daniels JR, Chak LY, Sikic BI, Lockbaum P, Kohler M, Carter SK, Reynolds R, Bohnen R, Gandara D, Yu J. Daniels JR, et al. Among authors: lockbaum p. J Clin Oncol. 1984 Nov;2(11):1192-9. doi: 10.1200/JCO.1984.2.11.1192. J Clin Oncol. 1984. PMID: 6092554 Clinical Trial.

8

Diagnostic accuracies of clinical studies in patients with small cell carcinoma of the lung.

Chak LY, Paryani SB, Sikic BI, Lockbaum P, Torti FM, Carter SK. Chak LY, et al. Among authors: lockbaum p. J Clin Oncol. 1983 May;1(5):290-4. doi: 10.1200/JCO.1983.1.5.290. J Clin Oncol. 1983. PMID: 6321683

9

Patterns of failure in small cell carcinoma of the lung.

Chak LY, Daniels JR, Sikic BI, Torti FM, Lockbaum P, Carter SK. Chak LY, et al. Among authors: lockbaum p. Cancer. 1982 Nov 1;50(9):1857-63. doi: 10.1002/1097-0142(19821101)50:9<1857::aid-cncr2820500933>3.0.co;2-i. Cancer. 1982. PMID: 6288227

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

9 results

Search Page